These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 18577934

  • 1. [Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache].
    Tarasova SV, Amelin AV, Skoromets AA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):43-6. PubMed ID: 18577934
    [Abstract] [Full Text] [Related]

  • 2. [Antidepressants with different action mechanisms in the treatment of chronic daily headache].
    Amelin AV, Tarasova SV, Ignatov IuD, Skoromets AA, Miatleva MI.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):38-44. PubMed ID: 18379461
    [Abstract] [Full Text] [Related]

  • 3. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L, Jensen R, Olesen J.
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
    [Abstract] [Full Text] [Related]

  • 4. [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
    Amelin AV, Skoromets AA, Korenko LA, Tumelevich BCh, Gonchar MA.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000 Sep; 100(8):20-3. PubMed ID: 10983362
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis.
    Bánk J.
    Headache; 1994 Sep; 34(8):476-8. PubMed ID: 7960733
    [Abstract] [Full Text] [Related]

  • 6. [Comparative efficacy and tolerance of fluvoxamine and amitriptyline in the treatment of moderate and severe depression in mental hospital].
    Kostiukova EG, Granenov GM, Andreĭchik LA, Serditov OV, Mosolov SN.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003 Sep; 103(1):24-9. PubMed ID: 12616734
    [Abstract] [Full Text] [Related]

  • 7. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [Abstract] [Full Text] [Related]

  • 8. Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications.
    Cerbo R, Barbanti P, Fabbrini G, Pascali MP, Catarci T.
    Headache; 1998 Jun; 38(6):453-7. PubMed ID: 9664750
    [Abstract] [Full Text] [Related]

  • 9. Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment.
    Rota E, Broda R, Cangemi L, Migliaretti G, Paccotti P, Rosso C, Torre E, Zeppegno P, Portaleone P.
    Psychiatry Res; 2005 Feb 28; 133(2-3):281-4. PubMed ID: 15741004
    [Abstract] [Full Text] [Related]

  • 10. [Review of double-blind studies comparing SSRI and SNRI].
    Suzuki E, Maruta S.
    Seishin Shinkeigaku Zasshi; 2004 Feb 28; 106(10):1203-17. PubMed ID: 15669214
    [Abstract] [Full Text] [Related]

  • 11. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache.
    Bendtsen L, Jensen R.
    Cephalalgia; 2000 Jul 28; 20(6):603-10. PubMed ID: 11075846
    [Abstract] [Full Text] [Related]

  • 12. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine.
    Manna V, Bolino F, Di Cicco L.
    Headache; 1994 Jan 28; 34(1):44-9. PubMed ID: 8132440
    [Abstract] [Full Text] [Related]

  • 13. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Grimsley SR, Jann MW.
    Clin Pharm; 1992 Nov 28; 11(11):930-57. PubMed ID: 1464219
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
    Morishita S, Arita S.
    Eur Psychiatry; 2003 Dec 28; 18(8):418-20. PubMed ID: 14680720
    [No Abstract] [Full Text] [Related]

  • 15. Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder.
    Dell'Osso B, Allen A, Hollander E.
    Expert Opin Pharmacother; 2005 Dec 28; 6(15):2727-40. PubMed ID: 16316311
    [Abstract] [Full Text] [Related]

  • 16. Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study.
    Descombes S, Brefel-Courbon C, Thalamas C, Albucher JF, Rascol O, Montastruc JL, Senard JM.
    Headache; 2001 Feb 28; 41(2):178-82. PubMed ID: 11251703
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline.
    Valguarnera F, Tanganelli P.
    Neurol Sci; 2010 Jun 28; 31 Suppl 1():S175-7. PubMed ID: 20464616
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression.
    Vezmar S, Miljkovic B, Vucicevic K, Timotijevic I, Prostran M, Todorovic Z, Pokrajac M.
    J Pharmacol Sci; 2009 May 28; 110(1):98-104. PubMed ID: 19444001
    [Abstract] [Full Text] [Related]

  • 20. Amitriptyline for inpatients and SSRIs for outpatients with depression? Systematic review and meta-regression analysis.
    Barbui C, Guaiana G, Hotopf M.
    Pharmacopsychiatry; 2004 May 28; 37(3):93-7. PubMed ID: 15179966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.